While the Trump administration targets COVID-19-related research, a new report from the ECDC shows the benefits of ...

The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months ...

"With the COVID pandemic behind us, it is time to adopt a common-sense approach to COVID policy," a spokesperson for the FDA ...

The FDA will continue recommending annual COVID-19 vaccines for older adults and high-risk groups, but says more clinical ...

Seattle vaccine experts were confused by the country's apparent new direction around updated COVID-19 shots, which top FDA ...

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, ...

The FDA’s new approach to boosters could mean that kids will no longer be able to get vaccinated against the disease to begin with.

Earlier this month, the US government announced a US$500 million (£377 million) investment to accelerate research into ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

New data suggests India's true COVID-19 death toll may be seven times higher than official figures, raising questions about ...